Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.80
Bid: 38.50
Ask: 39.00
Change: -0.30 (-0.77%)
Spread: 0.50 (1.299%)
Open: 40.00
High: 40.00
Low: 38.00
Prev. Close: 39.10
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Virgin Wines beats forecasts; Kape revenue surges

Tue, 20th Jul 2021 15:06

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Virgin Wines UK PLC - online wine retailer - Finishes financial year to June 30 positively with strong levels of customer demand in final two months. Revenue and earnings before interest, tax, depreciation and amortisation for the year are now anticipated to be marginally higher than previous expectations. Annual revenue expected to be GBP73.8 million, up 30% from the previous year. Ebitda expected to be GBP6.4 million, 45% higher year-on-year. Notes positive sales momentum has continued into July.

----------

Kape Technologies PLC - Isle of Man-headquartered digital security software provider - Says trading has been strong throughout the first half of 2021 and is in line with management's expectations for the full year. Posts record 79% increase in adjusted Ebitda for the first half of the year ended June 30. Revenue for the six-month period is expected to be around USD95.7 million, up 60% from previous year's comparative. Kape says it is confident of delivering revenue between USD197 million and USD202 million and adjusted Ebitda of between USD73 million and USD76 million for 2021.

----------

Dianomi PLC - London-based digital advertising services firm - Confirms strong first half trading and that the company is trading in line with market expectations for the full year. First half revenue is expected to demonstrate "significant growth" compared to the prior year as the group expands its customer base.

----------

Alliance Pharma PLC - pharmaceutical company based in Wiltshire - For six months ended June 30 trades strongly with see-through revenue of GBP80.9 million, 24% higher than the same period in the previous year. Expects underlying profit before tax for the full year to be in line with market expectations. Its consumer healthcare business performs particularly well, with half year revenue up 30% to GBP56.8 million. Anticipates strong trading will continue throughout the second half.

----------

Brand Architekts Group PLC - Teddington, south west London-based personal care and beauty products firm - Posts annual sales of GBP15.9 million, a decline of 2.5% on the prior year, as the pandemic impacts high-street footfall. First half sales are GBP9.0 million, down 10% on the prior year period. Second half sales are 10% better than prior year comparison at GBP6.9 million. Underlying operating profit for the year ended June 30 expected in line with the previous year. Notes that it is "confident" of achieving medium and long-term goals.

----------

Focusrite PLC - High Wycombe, Buckinghamshire-based music and audio products - Continues to trade well across all business units in second half, with demand remaining strong when compared with the corresponding pre-pandemic period in financial year 2020. As a result, now expects revenue for the full year to August 31 to be ahead of market expectations. Profit for the year is anticipated "significantly" ahead of expectations. Focusrite notes supply chain disruption due to the global shortage of semiconductors and other components, principally caused by the effects of Covid-19. The pandemic is also causing freight and shipping costs to be higher than normal for the firm.

----------

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Sep 2014 15:00

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
9 Sep 2014 05:27

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Sep 2014 15:15

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Sep 2014 05:43

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Sep 2014 14:56

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Sep 2014 05:23

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Sep 2014 15:10

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Sep 2014 05:23

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Sep 2014 15:12

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
9 Jul 2014 07:36

Alliance Pharma Says Flat Revenue Met Its Expectations

Read more
21 May 2014 09:59

Alliance Pharma Trading In Line With Expectations

LONDON (Alliance News) - Alliance Pharma PLC Wednesday said trading in the first four months of 2014 has been in line with expectations, following a robust trading performance in 2013. In a statement released ahead of its annual general meeting Wednesday the speciality pharmaceutical compan

Read more
21 May 2014 08:36

Wednesday broker round-up UPDATE

African Minerals: Citi reduces target price from 260p to 190p, while leaving its buy recommendation unchanged. Alliance Pharma: Numis lowers target price from 39p to 37p and maintains an add rating. APR Energy: JP Morgan shifts target price from 1082p to 1089p keeping its overweight rating. Astra

Read more
26 Mar 2014 16:09

Alliance Pharma's 2013 pre-tax profit rises

Alliance Pharma's annual pre-tax profit gained 11 per cent to 12m pounds, on the back of three acquisitions. The pharmaceutical company reported a 1.4% rise in revenue to £45.5m and a 6% increase in earnings per share to 3.82p. The company said growth was "underpinned by the continuing success o

Read more
26 Mar 2014 12:53

Alliance Pharma Lifts Its 2013 Dividend As Profit And Margins Rise

LONDON (Alliance News) - Alliance Pharma PLC raised its dividend as it saw pretax profit rise in 2013, benefiting from improved margins and growth in its Hydromol dermatology range. Alliance Pharma declared Wednesday a final dividend of 0.605 pence per share, bringing its total dividend for

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.